SUPERSELECTIVE ARTERIAL INFUSION AND CONCOMITANT RADIOTHERAPY FOR ADVANCED HEAD AND NECK CANCER
暂无分享,去创建一个
Y. Furuta | S. Fukuda | H. Shirato | H. Hatakeyama | T. Nishioka | A. Homma | S. Ushikoshi | F. Suzuki | T. Asano | T. Nagahashi
[1] Y. Furuta,et al. Rapid superselective high‐dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer , 2005, Head & neck.
[2] K. Robbins,et al. Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients , 2000, Head & neck.
[3] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[4] K. Robbins,et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. , 1999, Archives of otolaryngology--head & neck surgery.
[5] 下山正徳. National Cancer Institute-Common Toxicity Criteria (NCI-CTC Version 2.0, Jan. 30, 1998)-日本語訳JCOG版- , 1999 .
[6] C. Kerber,et al. An organ-preserving selective arterial chemotherapy strategy for head and neck cancer. , 1998, AJNR. American journal of neuroradiology.
[7] S. Howell,et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. , 1994, American journal of surgery.